Christopher Viehbacher

Christopher Viehbacher

Verkställande Direktör på BIOGEN INC.

Förmögenhet: 24 M $ per 2026-10-31

66 år
Health Technology
Commercial Services
Consumer Services

Profil

Christopher A. Viehbacher is the founder of Boston Pharmaceuticals, Inc. Current positions include President, Chief Executive Officer & Director at Biogen, Inc. since 2022; Chairman at PureTech Health LLC since 2015; Chairman at Braveheart Bio, Inc. starting 2025; Director at Zikani Therapeutics, Inc. since 2017; Director at CEO Roundtable on Cancer, Inc. since 2001; Director at Stanford University School of Medicine; Director at sanofi-aventis Philippines, Inc. since 2008; Director at Project Data Sphere LLC; Managing Partner at Gurnet Point Capital LLC; and Trustee at Northeastern University since 2015.
Former roles include Chairman & Chief Executive Officer at Glaxo Wellcome Plc in 2008; Chief Executive Officer & Director at Sanofi from 2008 to 2014; Chief Executive Officer at Sanofi-Aventis U.S.
LLC; Chairman at Pfizer Inc.; Chairman at Pharmaceutical Research & Manufacturers of America from 2010 to 2012; Chairman at Vedanta Biosciences, Inc.; Chairman at ERT Operating Co.; Vice Chairman at Nuvelution Pharma, Inc.; Chairman at PureTech Health Plc from 2019 to 2023; Director & Head-Pharmaceuticals Operations at GSK Plc in 2008; Director at The Burroughs Wellcome Fund; Director at Healthcare Leadership Council; Director at The Business Roundtable; Director at Corium LLC (Massachusetts); Director at Crossover Health, Inc.; Independent Director at Axcella Health, Inc. from 2015 to 2019; Director at Innocoll Biotherapeutics Holdings Ltd.; Director at BEFORE Brands, Inc.; Director at Alladapt Immunotherapeutics, Inc.; Principal at PricewaterhouseCoopers LLP; President at Genzyme Corp.
from 2012 to 2013; Member-International Business Council at Forum Mondial de L'Economie; President-Elect at European Federation of Pharmaceutical Industries & Assns in 2013; Board Member at Research!America; Member at The International Business Council; and President at GlaxoSmithKline LLC.
Education includes undergraduate studies at Queen's University.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
0,84 %
2026-08-07 759 857 ( 0,84 % ) 16 M $ 2026-10-31
2026-04-21 30 065 ( 0,02 % ) 8 M $ 2026-10-31

Aktiva positioner av Christopher Viehbacher

FöretagPositionStart
BIOGEN INC. Verkställande Direktör 2022-11-14
Ordförande 2015-01-01
Direktör/Styrelseledamot -
Direktör/Styrelseledamot 2015-01-01
Direktör/Styrelseledamot 2017-10-05
Direktör/Styrelseledamot -
Direktör/Styrelseledamot 2008-12-01
Direktör/Styrelseledamot -
Privat kapitalinvesterare -

Tidigare kända positioner av Christopher Viehbacher

FöretagPositionSlut
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░ ░░░ ░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Se detaljerna i Christopher Viehbachers erfarenhet

Christopher Viehbachers utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

91

Första gradens relationer

37

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag37

Health Technology

Health Technology

Health Technology

Technology Services

Commercial Services

Health Technology

Health Technology

Retail Trade

Health Technology

Consumer Services

Consumer Services

Finance

Miscellaneous

Health Technology

Health Services

Commercial Services

Commercial Services

Commercial Services

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Services

Health Technology

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Non-Durables

Health Technology

Technology Services

  1. Börsen
  2. Insiders
  3. Christopher Viehbacher